22nd International Conference of FFC - 10th International Symposium of ASFFBC

Functional Foods and Chronic Diseases: Science and Practice

September 22-23, 2017, at Harvard Medical School, Boston, MA, USA


Main Conference Topics/Sessions

Session: Functional Food Definition and the Status of Functional Foods in Japan, China, USA and other Countries

  • The regulations, policy, and labeling of functional foods in Japan 
  • Weaknesses and strong points of FOSHU/Food for Special Health Usage
  • The regulations, policy, and labeling of functional foods in China 
  • What is the status of Functional Foods in the USA? Expert opinions from NIH, USDA, and FDA
  • How the new definition of Functional Foods can help to improve the status of functional foods word wide

Session: Functional Foods and Obesity

  • Epidemiology of obesity
  • The modern mechanisms of obesity; energy metabolism and obesity; neurobiological mechanisms of obesity; microbiological mechanisms of obesity; pathophysiologic mechanisms of obesity
  • Biomarkers of obesity
  • The effects of functional food and bioactive compounds on biomarkers of obesity
  • Medical foods for obesity

Session: Functional Foods and Diabetes

  • Epidemiology of diabetes
  • The modern mechanisms of diabetes
  • Biomarkers of diabetes
  • The effects of functional food and bioactive compounds on biomarkers of diabetes
  • Medical foods for diabetes

Session: Functional Foods and Neurological Diseases

  • Epidemiology of mental and neurological diseases
  • Mechanisms of neurological diseases
  • Biomarkers of different mental and neurological diseases
  • The effects of functional food and bioactive compounds on biomarkers of neurological diseases
  • Functional foods for mental and neurological diseases 
  • Medical foods for neurological diseases

Session: Functional Foods and Cardiovascular Diseases (CVD)

  • Epidemiology of CVD
  • Biomarkers of different cardiovascular diseases
  • The effects of functional food and bioactive compounds on biomarkers of cardiovascular diseases
  • Medical foods for CVD

Session: Functional Foods and Cancer

  • Epidemiology of Cancer
  • Biomarkers of different types of cancer
  • The effects of functional food and bioactive compounds on biomarkers of different types of cancer
  • Medical Foods for the Cancer

Session: Functional Foods with Bioactive Compound(s): Prevention and Management of Non-communicable Diseases

  • Functional foods and other non-communicable diseases
  • Bioactive compounds and other non-communicable diseases
  • The effects of medical food on biomarkers of non-communicable diseases

Session: Safety of the Bioactive Compounds and Functional Foods

  • Food-Drug Interactions
  • Safety of bioactive compounds at efficacious levels
  • Safety of  functional foods at efficacious levels
  • Regulatory issues and health claims

Special Session: Prebiotics, Probiotics, and Cancer

Special Session: Nanotechnology for drug and bioactive compounds delivery systems: session chair: Rangel-Vázquez, PhD, Research Professor at Technological Institute of Aguascalientes (ITA), Mexico 

Special Session: Prevention and Management of Dementia

Session: Current Research and Development of New Functional Food Products.

  • Incentives for functional food research and development
  • Consumer acceptance of functional food products
  • Functional food composition and dietary intake databases
  • Food vehicles for delivery bioactive compounds
  • Research, development and marketing of new functional food products